Research And Markets - Pharmaceutical Sales Force Strategies Are Driving ROI Through Best Practice In Targeting, Management, Outsourcing And Technologies

Research and Markets (researchandmarkets.com/reports/c11431) has announced the addition of Pharmaceutical Sales Force Strategies: Driving ROI Through Best Practice in Targeting, Management, Outsourcing and Technologies to their offering.

(PRWEB) January 4, 2005 -- Research and Markets (http://www.researchandmarkets.com/reports/c11431) has announced the addition of Pharmaceutical Sales Force Strategies: Driving ROI Through Best Practice in Targeting, Management, Outsourcing and Technologies to their offering.

The management report 'Pharmaceutical Sales Force Strategies: Driving ROI through best practice in targeting, management, outsourcing and technologies' provides a detailed analysis of current trends in commercial ROI across the pharmaceutical, biotechnology and specialty pharmaceutical industries. Continued sales force growth has resulted in increasingly aggressive promotion to physicians, reducing the average duration of detailing visits and diluting 'share of voice' with the physician. Changes in physicians' information needs across a product's lifecycle has resulted in requirements for more responsive and flexible promotional efforts. New sales force tactics are being considered within Europe, US and Japan, such as the implementation of new CRM approaches, investment into new technologies and partnering with commercial alliance partners. This reports case studies and primary research with current industry leaders provides unique strategic insight. Examine the best practises that will help you drive ROI in your pharmaceutical sales force and will boost your product up-take, with the help of this report.

This report answers the questions:

- What key factors are driving the increasing attention paid to improving sales force effectiveness in the pharmaceutical industry?

- What are the key levers of sales force effectiveness in the

pharmaceutical industry and what will deliver the greatest ROI?

- What are the key trends in sales force size and detailing frequency?

- What are the key drivers of sales force effectiveness in the future?

- Which companies are using best practise to deliver sales force

effectiveness?

- What are the key trends in the use of CSOs and commercial alliances as potential sources of improved sales force effectiveness?

- How can new technologies deliver benefits to pharmaceutical sales?

forces?

Reasons to purchase this report:

- Identify the most suitable cost effective strategies that will

optimize your companys sales force performance.

- Analyze leading companies strategies, such as Allergan and Pfizer, with detailed case studies.

- Determine your optimal strategy by utilizing ROI evaluations

which provide a framework for different companies in different

contexts.

- Evaluate your internal sales force effectiveness program by

benchmarking your company against competitors, with studies from

Pfizer, AstraZeneca, Allergan and Takeda.

- Benefit from targeted recommendations on targeting, management,

outsourcing and technologies

- Examine the current best practises that senior pharmaceutical sales executives have identified within our survey.

The contents of this reports are as follows:

Executive summary 10

Pharmaceutical sales force landscape 10

Sizing, structuring and targeting 11

Recruiting, training and rewarding 12

Enabling technologies 13

Outsourcing and partnering 13

Strategies for increasing promotional ROI 15

Chapter 1 Pharmaceutical sales force

Chapter 2 Sizing, structuring and targeting 45

Chapter 3 Recruiting, training and

Chapter 4 Enabling technologies 80

Chapter 5 Outsourcing and partnering 101

For more information visit http://www.researchandmarkets.com/reports/c11431

Laura Wood

Senior Manager

Research and Markets

press@researchandmarkets.com

Fax: +353 1 4100 980

###